LONDON, May 14, 2021 (GLOBE NEWSWIRE) — Ferroglobe PLC (NASDAQ:GSM) (“Ferroglobe” or the “Company”), a leading producer of silicon metal, silicon-based alloys and manganese-based specialty alloys, is pleased to announce today that it has appointed Belen Villalonga, Silvia Villar-Mir de Fuentes, Nicolas De Santis, and Rafael Barrilero Yarnoz to the board of directors effective May 13, 2021.
Ferroglobe further announced that Bruce Crockett has been appointed to serve as lead independent director of its board of directors, effective May 13, 2021. Mr. Crockett has served on the board of Ferroglobe since its formation in 2015, and currently serves as the chairman of the audit committee.
“We are pleased to welcome Belen, Silvia, Nicolas and Rafael as new directors to Ferroglobe's board,” said Javier López Madrid, Ferroglobe's Executive Chairman. “They join the Company at an exciting time as we execute our strategic turnaround plan aimed at transforming the company and bolstering its long-term competitiveness. The addition of these directors to our board complements our current directors' skills and experiences, and we are confident they will provide valuable perspectives and support to management, as we continue to execute our strategy, drive profitability and enhance value for all Ferroglobe stakeholders. We look forward to their contributions and are excited they have chosen Ferroglobe.”
Belen Villalonga is a Professor of Management and Organizations, a Yamaichi Faculty Fellow, and a Professor of Finance (by courtesy) at New York University's Stern School of Business. Between 2001 and 2012 she was a faculty member at the Harvard Business School. Her teaching, research, and consulting activities are in the areas of corporate governance, strategy, and finance, with a special focus on family-controlled companies. Her award-winning research has been cited over 15,000 times in scholarly articles and international media outlets. Professor Villalonga is an independent director and audit committee member (and former chair) at Grifols, a global leader in hemoderivatives that is part of Spain's IBEX35 blue-chip index and is also listed on Nasdaq. She is also a member of the board and of the risk, audit, and compensation & talent management committees …
Full story available on Benzinga.com